AI brief of an SEC Form 8-K · INVO Fertility, Inc. (IVF)

INVO Fertility posts investor presentation; discloses $3.6 million in share sales to Alumni Capital

Neutral Impact 2 of 5 financing Written later

INVO Fertility furnished an investor presentation for use at the H.C. Wainwright 28th Annual Global Investment Conference, September 14 to 16, 2026, and disclosed that it has sold 2,094,395 shares to Alumni Capital LP under a July 24, 2026 purchase agreement for approximately $3,591,000. Shareholders may note the ongoing share sales, which add to the outstanding share count, under a facility with a commitment amount of up to $15 million that could be increased to $50 million by mutual agreement.

Key points

  • Investor presentation to be used at H.C. Wainwright 28th Annual Global Investment Conference, September 14 to 16, 2026, and posted to the Investors section of the company website on August 28, 2026
  • Shares sold to Alumni Capital LP since SEC effectiveness: 2,094,395 shares for approximately $3,591,000, at an approximate average of $1.71 per share
  • Purchase agreement dated July 24, 2026 allows the company to sell up to $15 million in shares, with an option to increase to $50 million by mutual written agreement

The filing

CompanyINVO Fertility, Inc. (IVF)
Form8-K, current report
Filed with the SECAug 28, 2026, 8:30 AM ET
Accession number0001493152-26-040504

Items reported: 7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 28, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.